JPA Health

DNDi and Atomwise collaborate to advance drug development using AI for neglected diseases

DNDi and Atomwise collaborate to develop first-in-class treatments for Chagas disease using AI, delivering drug-like compounds that will undergo further optimization and potential drug development. The research aims to address a public health challenge affecting millions worldwide.

SourceJPA Health·DateApr 16, 2019

UConn researchers see promising early results in drug discovery partnership with AI Biotech Company

Researchers at UConn are using Atomwise's AI-powered in silico screening technology to develop therapeutic treatments for ischemic strokes, hand-foot-and-mouth disease, and a pig infection. Early successes have been reported by three researchers, including Rajkumar Verma and Simon White.

SourceJPA Health·DateApr 9, 2019